Location History:
- Erfstadt, DE (2010)
- Erftstadt, DE (2014)
Company Filing History:
2 out of 5,444 
2 out of 3,688 
Years Active: 2010-2014
Title: Innovations of Tilman Schneider-Poetsch
Introduction
Tilman Schneider-Poetsch is a notable inventor based in Erftstadt, Germany. He has made significant contributions to the field of immunosuppressive agents and anticancer therapies. With a total of two patents to his name, his work focuses on developing novel compounds that target translation initiation factors.
Latest Patents
Schneider-Poetsch's latest patents include compositions that are simplified analogs of pateamine A. These analogs are devoid of the C3-amino and C5-methyl groups, referred to as desmethyl, desamino-pateamine A. They exhibit potent immunosuppressive properties and provide anticancer and antiproliferative effects both in vivo and in vitro. The mechanism of action involves the inhibition of eIF4A-dependent translation initiation, leading to cell cycle arrest or apoptosis in transformed cells. Importantly, these compounds show low toxicity to slow-growing normal cells, making them promising candidates for therapeutic use.
Career Highlights
Throughout his career, Schneider-Poetsch has worked with prestigious institutions, including the Texas A&M University System and Johns Hopkins University. His research has significantly advanced the understanding of molecular probes for evaluating eukaryotic translation initiation and developing improved anticancer agents.
Collaborations
Some of his notable coworkers include Daniel Romo and Jun O Liu, who have contributed to his research endeavors.
Conclusion
Tilman Schneider-Poetsch's innovative work in the field of immunosuppressive agents and anticancer therapies highlights his importance as an inventor. His contributions continue to pave the way for advancements in cancer treatment and molecular biology.